The Immune-Buffer COVID-19 Exit Strategy that Protects the Elderly
View ORCID ProfileVered Rom-Kedar, Omer Yaniv, Roy Malka, Ehud Shapiro
doi: https://doi.org/10.1101/2020.09.12.20193094
Vered Rom-Kedar
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
3The Estrin Family Chair of Computer Science and Applied Mathematics.
Omer Yaniv
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
Roy Malka
2Lynx MD, Tel Aviv, Israel.
Ehud Shapiro
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
Article usage
Posted September 14, 2020.
The Immune-Buffer COVID-19 Exit Strategy that Protects the Elderly
Vered Rom-Kedar, Omer Yaniv, Roy Malka, Ehud Shapiro
medRxiv 2020.09.12.20193094; doi: https://doi.org/10.1101/2020.09.12.20193094
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)